InvestorsObserver
×
News Home

Do Traders Think Kezar Life Sciences Inc (KZR) Can Turn Around Friday?

Friday, March 03, 2023 11:02 AM | InvestorsObserver Analysts

Mentioned in this article

Do Traders Think Kezar Life Sciences Inc (KZR) Can Turn Around Friday?

Overall market sentiment has been down on Kezar Life Sciences Inc (KZR) stock lately. KZR receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bearish
Kezar Life Sciences Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on KZR!

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With KZR Stock Today?

Kezar Life Sciences Inc (KZR) stock is trading at $5.63 as of 10:58 AM on Friday, Mar 3, a rise of $0.20, or 3.78% from the previous closing price of $5.43. The stock has traded between $5.49 and $5.76 so far today. Volume today is low. So far 153,017 shares have traded compared to average volume of 535,804 shares. To screen for more stocks like Kezar Life Sciences Inc click here.

More About Kezar Life Sciences Inc

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as KZR-616, and the protein secretion program. Click Here to get the full Stock Report for Kezar Life Sciences Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App